Results 131 to 140 of about 984,354 (150)
Correction to "The emerging role of IL-38 in diseases: A comprehensive review". [PDF]
Immun Inflamm Diseuropepmc +1 more source
IL-38 attenuates renal ischemia/reperfusion injury through suppressing inflammation in mice
Cellular and Molecular BiologyDecui, Liang +3 more
openaire +2 more sources
Preliminary study for a numerical aerodynamic simulation facility [PDF]
Bonstrom, D. B. +4 more
core +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
IL-38 in modulating hyperlipidemia and its related cardiovascular diseases
International Immunopharmacology, 2022Hyperlipidemia is confirmed to be associated with several health problems that include the combination of diabetes mellitus, obesity, and hypertension, ie, metabolic syndrome. Although the lipid-lowering therapy is an effective treatment in hyperlipidemia and its related cardiovascular diseases (CVDs), the persistence of high atherosclerotic risk is ...
Min, Lai +5 more
openaire +2 more sources
Powerful anti‐inflammatory action of luteolin: Potential increase with IL‐38
BioFactors, 2021AbstractLuteolin belongs to the flavone family originally present in some fruits and vegetables, including olives, which decrease intracellular levels of reactive oxygen species (ROS) following the activation of various stimuli. Luteolin inhibits inflammation, a complex process involving immune cells that accumulate at the site of infectious or non ...
Conti, Pio +9 more
openaire +2 more sources
IL-38 as an early predictor of the ischemic stroke prognosis
Cytokine, 2021Ischemic stroke is caused by a sudden neurological defect following a vascular occlusion and elicits a local and systemic inflammation in brain tissue. Interleukin-38 is an anti-inflammatory cytokine associated with ischemic and inflammatory diseases. This study was designed to analyze the effect of tPA therapy on interleukin-38 serum level changes and
Maryam Zare Rafie +5 more
openaire +2 more sources
IL-38, a potential therapeutic agent for lupus, inhibits lupus progression
Inflammation Research, 2022Previous studies reported that IL-38 was abnormally expressed in patients with systemic lupus erythematosus (SLE). However, the involvement of IL-38 in the pathophysiology of SLE remains unknown.The therapeutic potential of IL-38 was tested in pristane-treated wild-type (WT) and IL-38-/- mice. Thus, SLE was induced via pristane in WT and IL-38-/- mice.
Wang-Dong, Xu +8 more
openaire +2 more sources
IL-38 alleviates concanavalin A-induced liver injury in mice
International Immunopharmacology, 2016Interleukin (IL)-38 is a poorly characterized cytokine of the IL-1 family with anti-inflammatory activity. The role of IL-38 in liver injury remains unknown. We have investigated the potential effect of hydrodynamic-based gene delivery to express human IL-38 in mice with concanavalin A (Con A)-induced liver injury.
Xianli, Yuan +7 more
openaire +2 more sources
Association between IL-38 and inflammatory indicators in patients with bacterial pneumonia
Cytokine, 2023IL-38, a recently discovered cytokine of IL-1 family, exerts immunoregulatory activities in multi-type inflammatory diseases. However, its expression level and underlying clinical importance for IL-38 in respiratory bacterial infections remain unknown.Thirty-five patients with bacterial pneumonia and twenty age- and gender- matched healthy individuals ...
Xiaoyu Sun +6 more
openaire +2 more sources